Skip to main content

Cam Jurgens Went to Colombia for Stem Cell Treatment — Should Eagles Fans Be Concerned?

T

The JAKIB Staff

contributor

3 min read

Cam Jurgens posted photos from Medellín, Colombia this week, showing IV bags labeled with "GoBirds" messaging as he underwent stem cell treatment for his back. It was framed as a positive, proactive step in his recovery. But reading between the lines, there are legitimate reasons for concern.

When an NFL player travels internationally for medical treatment that's available domestically, it raises questions. Stem cell treatments in the United States are heavily regulated by the FDA, which limits certain procedures that are more freely available in other countries. Going to Colombia suggests Jurgens is pursuing treatments that either aren't available or aren't approved in the U.S.

That's not necessarily a red flag on its own. Athletes across professional sports have sought cutting-edge treatments abroad, and some have returned better than ever. But it does suggest that the back issue is more significant than a routine injury that conventional rehab can fix.

Jurgens' back problems contributed to a miserable 2025 season for the offensive line. He had surgery in the offseason, missed OTAs and minicamp entirely, and was never fully right during the regular season. The tush push — the play that defined Philadelphia's offensive identity — took a particular toll on the center position, and Jurgens bore the brunt of it.

The timing matters too. We're in late February, and Jurgens is still seeking treatment for an injury from last season. Training camp is roughly five months away. That's enough time for recovery, but it doesn't leave much margin for setbacks.

If the stem cell treatment works, it could be a game-changer. Regenerative medicine has shown promising results for certain types of back injuries, and Jurgens is young enough that his body should respond well to the treatment. The best-case scenario is that he returns fully healthy and puts the back issues behind him entirely.

The worst-case scenario is that the treatment doesn't provide lasting relief, and Jurgens enters 2026 managing a chronic back condition. For a center — a position that requires explosive movement on every single snap — that would be devastating.

The Eagles need to prepare for both outcomes. If Jurgens is healthy, he's one of the best young centers in football and a cornerstone of the offensive line. If he's not, the Eagles need a viable backup plan at the most important position on the offensive line.

Jason Kelce, who knows this position better than anyone, has been vocal about the toll the tush push took on the linemen. It's worth noting that the NFL competition committee has declined to ban the play — but the Eagles might need to retire it voluntarily if it means protecting Jurgens' long-term health.

Hope for the best. Plan for the worst. That's the only responsible approach to Cam Jurgens' situation right now.

Support independent Eagles coverage

Explore JAKIB membership and find the option that works for you.

Explore membership
T

The JAKIB Staff

AI-powered content assistant for JAKIB Sports. Articles generated from show transcripts and Eagles coverage.

Share this article

Related Articles

Analysis

Caleb Williams’ Improvement Starts With the Structure Around Him

Caleb Williams completed 70.9 percent of his passes across five starts through Week 8. Protection, run-game connections and continuity offer a framework for examining the improvement without taking credit away from the quarterback or treating a small sample as causal proof.

Analysis

The Eagles’ Backup Quarterback Problem Is Bigger Than One Bad Start

The Eagles invested in backup quarterbacks. The harder question is whether practice work, scheme fit and a usable replacement plan prepared the offense to function when the quarterback changed.

Analysis

The Eagles Trade Deadline Is About Value, Not a Roster Fire Sale

The Eagles can move veterans without dismantling their next roster. Replacement costs, actual buyer demand and conditional compensatory value should set the price.

Analysis

The Eagles Need an Evaluation Plan for Their Young Players

The Eagles should give young players defined jobs and meaningful opportunities to show progress. Availability, clear teaching and comparable assignments matter more than an empty snap total.

Analysis

The Eagles’ Defensive Contracts Have Put Accountability Under the Microscope

Long-term commitments to Jalen Carter and Jordan Davis raise the stakes for Philadelphia’s weekly defensive decisions. The Eagles can demand clearer execution and adjust roles without turning a poor performance into an unsupported verdict on effort.

Opinion

Jeffrey Lurie’s Honor Arrives Amid an Eagles Trust Problem

Jeffrey Lurie’s Eagles Hall of Fame induction recognizes a championship legacy. Fans can appreciate that history while expecting clearer public communication from the organization’s leadership.